IUCRC Phase II Georgia Institute of Technology: Building Reliable Advances and Innovations in Neurotechnology (BRAIN)

由于可存活创伤的增加和人口老龄化，残疾正在成为医疗保健关注的主要原因。数百万成年人患有神经系统疾病、脑损伤、精神疾病、肢体丧失或瘫痪。需要可获得的技术，以便更有效地满足这些患者的护理和康复需求。然而，神经技术的创新面临着几个挑战：创新的速度超过了可接受性能的评估速度；神经技术的安全性、有效性和可靠性验证标准滞后；目前的技术价格昂贵，限制了它们在治疗残疾方面的应用；在新兴技术方面培训新一代医生和工程师的需求也在稳步增长。建立可靠的神经技术进步和创新的产学研合作研究中心（IUCRC BRAIN）将解决上述挑战。该中心的愿景是建立在一个融合的研究方法，以设计和验证可靠的，道德的，以患者为中心的神经技术及其在理解神经系统中的应用。BRAIN利用从神经、认知和康复工程到神经机器人、神经调节和伦理人工智能的广泛专业知识，通过与行业和其他战略合作伙伴的合作，提高新神经技术的开发速度和经验验证，同时培养一支高技能的劳动力队伍；评估这些技术对生活质量的影响；并将跨学科的知识，如人文学科，与神经技术相结合，以理解集体智慧，增强身体和认知能力。该中心的使命是多重的：通过将神经技术转移给最终用户来加速科学进步和促进国民健康，并通过扩大新的参与和保留现有参与者来促进代表性不足的少数民族在科学、技术、工程和数学（STEM）领域的参与。BRAIN将解决神经学领域的问题，这些问题不成比例地影响到代表性不足的群体。BRAIN将通过创建从发现到解决方案的管道，成为神经技术中心，同时帮助学生、科学家和工程师解决我们这个时代最大的未满足的医疗和保健需求之一。佐治亚理工学院网站是大脑中心的合作伙伴网站，补充了现有的力量，并将研究扩展到脑损伤、神经血管工程和细胞系统等新领域。作为培训弱势群体的领先公共机构，佐治亚理工学院将扩大现有项目，纳入神经技术重点。中心将在本项目完成后的10年内维持一个包含产品和服务的项目储存库（https://nsfbrain.org/）。该奖项反映了美国国家科学基金会的法定使命，并通过使用基金会的知识价值和更广泛的影响审查标准进行评估，被认为值得支持。

Disability is becoming a leading cause of healthcare concern because of the increase in survivable trauma and an aging population. Millions of adults live with neurological disorders,brain injury, mental illness, limb loss or paralysis. There is a need for accessible technologies that can more effectively address the care and rehabilitation needs of these patients. However, innovation in neurotechnology faces several challenges: The pace of innovation exceeds the rate of evaluation for acceptable performance; standards for the validation of safety, efficacy, and reliability of neurotechnology are lagging; current technologies are costly, limiting their deployment for treatment of disabilities; and the need to train new generations of physicians and engineers in emerging technologies steadily increases.The Industry University Cooperative Research Center for Building Reliable Advances and Innovations in Neurotechnology (IUCRC BRAIN) will address the above challenges. The Center's vision is built on a convergent research approach to the design and validation of reliable, ethical, patient-centered neurotechnologies and their use in understanding neural systems. BRAIN leverages wide-ranging expertise from neural, cognitive and rehabilitation engineering to neurorobotics, neuromodulation, and ethical artificial intelligence to enhance the rate of development and empirical validation of new neurotechnologies through partnerships with industry and other strategic partners while developing a highly skilled workforce; evaluating the impact of these technologies on quality of life; and integrating knowledge across disciplines, such as the humanities, with neurotechnologies to understand collective intelligence, and augment physical and cognitive capabilities.The Center's mission is multifold: to accelerate the progress of science and advance the national health by transferring neurotechnology to end users and to promote access for underrepresented minorities in science, technology, engineering, and math (STEM) by broadening new participation and retaining current participants. BRAIN will address problems in the neurological space that disproportionately affect underrepresented groups. BRAIN will become a neurotechnology hub by creating a pipeline from discoveries to solutions, while helping students, scientists, and engineers solve one of the greatest unmet medical and healthcare needs of our time.The Georgia Tech site, a Partner Site of the BRAIN Center complements existing strength and expands research into new areas such as brain injury, neurovascular engineering, and cell based systems. As a leading public institution for training of underrepresented groups, Georgia Tech will expand existing programs to include a neurotechnology focus. The Center will maintain a project repository (https://nsfbrain.org/) comprised of products and services for 10 years after the completion of this project.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.